Wilson, Sharon and Kodiattu, Sara Kurien and Harikrishnan, S and Rojin, Kavya Annie and Jesurun, R S Jacob (2025) Mefenamic acid and renal health: Unveiling the risks. World Journal of Biology Pharmacy and Health Sciences, 23 (1). pp. 323-328. ISSN 2582-5542
![[thumbnail of WJBPHS-2025-0679.pdf]](https://eprint.scholarsrepository.com/style/images/fileicons/text.png "WJBPHS-2025-0679.pdf")
Article PDF
WJBPHS-2025-0679.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.
Abstract
Mefenamic acid is a non-selective non-steroidal anti-inflammatory drug (NSAIDs) used in the management of pain and inflammation. They are non-opioid analgesics. They inhibit the synthesis of prostaglandins in body tissues by inhibiting COX-1 and COX-2. Thus inhibits the synthesis of prostaglandins, reducing blood supply to the kidneys. Hence, there is always a possibility of kidney injury after administration of Mefenamic acid. We hereby present a series of 7 patients where they developed kidney injury while on treatment with Mefenamic acid.
| Item Type: | Article |
|---|---|
| Official URL: | https://doi.org/10.30574/wjbphs.2025.23.1.0679 |
| Uncontrolled Keywords: | Mefenamic Acid; NSAID; Pain and Inflammation; CKD; Acute Kidney Injury; DIKI |
| Depositing User: | Editor WJBPHS |
| Date Deposited: | 20 Aug 2025 12:16 |
| Related URLs: | |
| URI: | https://eprint.scholarsrepository.com/id/eprint/4154 |